The Injection of Ghrelin (OXE-103) Improves Subacute Concussion Symptom Burden and Quality of Life

The Injection of Ghrelin (OXE-103) Improves Subacute Concussion Symptom Burden and Quality of Life

Concussions remain the leading form of traumatic brain injury. Despite this, there is a paucity of pharmacologic and evidence-based treatments. The objective of this study was to investigate the benefit of Ghrelin (OXE-103) as a novel treatment for subacute concussion. The study consisted of an open...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael Rippee, Michael Wyand, Jamie Chen, Amelia Kirchhoff-Rowald, Suzanne Hunt, Vishal Bansal
Format: Article
Language:English
Published: Mary Ann Liebert 2025-01-01
Series:Neurotrauma Reports
Subjects:
concussion
drug therapy
ghrelin
mild traumatic brain injury
Online Access:https://www.liebertpub.com/doi/10.1089/neur.2025.0038
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items